Open AccessImpact of COVID-19 on Outpatient Antimicrobial Prescribing Patterns in New York City
Author(s) -
Monica Douglas,
Stanley Moy,
Nubriel Hernandez
Publication year - 2021
Publication title -
infectious diseases in clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.145
H-Index - 21
eISSN - 1536-9943
pISSN - 1056-9103
DOI - 10.1097/ipc.0000000000001071
Subject(s) - medicine , hydroxychloroquine , azithromycin , antimicrobial , medical prescription , antimicrobial stewardship , pediatrics , outpatient clinic , intensive care medicine , antibiotics , emergency medicine , antibiotic resistance , covid-19 , disease , infectious disease (medical specialty) , pharmacology , chemistry , organic chemistry , microbiology and biotechnology , biology
Antibiotic and antiviral agents may be prescribed in patients with suspected or confirmed coronavirus disease 2019 (COVID-19) infections because of in vitro evidence of cessation of viral replication, potential bacterial secondary or coinfection, and inability to distinguish COVID-19 infections from common bacterial infections. The objective of this study was to evaluate antimicrobial prescribing patterns in the outpatient setting during the initial peak of COVID-19 in New York City.